Nisa Investment Advisors
CDMO

Nisa Investment Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Nisa Investment Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,241
Closed -$15.3K – 3088
2024
Q4 		$15.3K Buy
1,241
+105
+9% +$1.2K ﹤0.01% 2022
2024
Q3 		$12.9K Hold
1,136
– – ﹤0.01% 2042
2024
Q2 		$8.11K Buy
1,136
+376
+49% +$2.88K ﹤0.01% 2200
2024
Q1 		$5.09K Buy
760
+15
+2% +$103 ﹤0.01% 2116
2023
Q4 		$4.84K Buy
745
+15
+2% +$97 ﹤0.01% 2125
2023
Q3 		$6.89K Sell
730
-21
-3% -$253 ﹤0.01% 2239
2023
Q2 		$10.5K Sell
751
-2,259
-75% -$38.5K ﹤0.01% 2249
2023
Q1 		$56K Sell
3,010
-450
-13% -$7.39K ﹤0.01% 1685
2022
Q4 		$48K Sell
3,460
-47
-1% -$720 ﹤0.01% 1793
2022
Q3 		$59K Buy
3,507
+47
+1% +$856 ﹤0.01% 1689
2022
Q2 		$53K Buy
3,460
+2,750
+387% +$40.7K ﹤0.01% 1715
2022
Q1 		$14K Sell
710
-290
-29% -$5.91K ﹤0.01% 2142
2021
Q4 		$19K Sell
1,000
-4,000
-80% -$114K ﹤0.01% 1930
2021
Q3 		$108 Hold
5,000
– – ﹤0.01% 1664
2021
Q2 		$128 Buy
+5,000
New +$107K ﹤0.01% 1581

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Nisa Investment Advisors's CDMO Position: Q1 2025 in Review

Nisa Investment Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 1,241 shares — an estimated $15.3K sold.

Nisa Investment Advisors first reported a position in CDMO in Q2 2021 and held it in 15 quarters. The position peaked at $59K in Q3 2022. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Nisa Investment Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 1,241 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $15.3K.
  • Nisa Investment Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2021 and held it in 15 quarters.
  • Nisa Investment Advisors's Avid Bioservices, Inc. Common Stock position peaked at $59K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Nisa Investment Advisors's 13F filing for Q1 2025, filed 30 Apr 2025.